ARBUCKLE STUART A (EVP\Chief Commercial Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/19/2025ACC: 0000875320-25-000081
Officer· EVP\Chief Commercial Officer
Since Jun 2018
-2.72K
Net shares
Net seller
$1.26M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.72K
Price / share
$463.46
Trade value
$1.26M
% of position
3.5%
2/14/2025
77.45K→74.72K
Total
Net shares
−2.72K
Net value
-$1.26M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2025 | F · Tax Withholding | −2.72K | $463.46 | $1.26M | 3.5% | 77.45K | 74.72K |
| Total | −2.72K | -$1.26M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned140.00
Total
140.00 indirect140.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 140.00 | Indirect |
| Total | 140.00 | 140.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported